Tagged with Biotech,

China Dr Li Shuai of pain- and CNS-focused Chinese biotech SIMR outlines the history of the company, the unmet medical needs it is seeking to address, its partnership strategy, and the complexities of attracting and retaining talent in the highly competitive Chinese market.   In 2014, my first angel investor actually…

Taiwan Francis Hong, chairman of Taiwan Medical and Biotech Industry Association (TMBIA), takes a moment during the 2019 Medical Taiwan and Taiwan Medical Components & Manufacturing Expo (MCMEX) in Taipei to share the mission of the Association, key issues being faced by its members, and an overview of Taiwan’s medical device landscape…

Taiwan Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer her insights on the key market trends impacting the emerging field of precision medicine and shares her outlook on the…

Taiwan Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus Antrodia Camphorata. The company’s drug, Hocena®, has already received several orphan drug designations and thus far has exhibited promising results in key indications such as pancreatic cancer, non-small cell lung…

China Zhenkun Ma, founder and CEO of TenNor Therapeutics, shares his cross-sectorial experiences in Big Pharma, biotech and non-profit organization that led to the establishment of TenNor Therapeutics; their mission to develop highly differentiated therapies for infectious diseases with clear unmet medical needs, such as biofilm-associated medical device infections, H. pylori…

China The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics’ CAR-T cell therapy CT053 for multiple myeloma after positive results were observed in the phase I trial efficacy evaluation.   19 of 24 patients with relapsed and refractory multiple myeloma showed complete response Zonghai Li, CARSgen Therapeutics…

Taiwan Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique role in supporting Foxconn’s transition into healthcare. Li also shares his insights on the top challenges facing Taiwan’s innovation and entrepreneurial landscape.   H Spectrum is now positioned…

China Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making waves in the world’s second-largest pharmaceutical market, China. Here, we pick out five more firms looking to crack both the Chinese and international markets.   EpimAB Biotherapeutics Founded in 2015, EpimAb Biotherapeutics is a privately owned…

Sweden Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical need. Last October, Dr Uli Hacksell was appointed CEO to reorganize the company in order to focus resources on the clinical development of Medivir’s projects. He presents the progress…

Thailand Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current research in biotechnology and genomics projects, as well as the local and international collaboration they have in place to further develop the strengths of Thailand in the field.   Currently, estimations…

China Dr Kai Lamottke, co-founder and MD of Bicoll GmbH, Munich, and since 2001, GM and board member of Bicoll Biotechnology (Shanghai) Co. Ltd discusses Bicoll’s presence in both the Chinese and European markets, its unique Bicoll Plant ProfilesTM (fine fractions derived from plant extracts fractionated by Bicoll’s innovative isolation system…

Taiwan Taiwan’s biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the island’s total biopharmaceutical market, along with pharmaceuticals and medical devices. Made with Visme Infographic Maker   The stock market capitalization of Taiwan’s biotech sector soared from USD 3.4 billion in 2007 to USD…